tiprankstipranks
Evgen Pharma PLC (GB:TCF)
LSE:TCF

Evgen Pharma (TCF) Technical Analysis

1 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
3Neutral
14Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Evgen Pharma PLC’s (TCF) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Evgen Pharma PLC is a Buy.
Evgen Pharma PLC’s (TCF) 20-Day exponential moving average is 0.84, while Evgen Pharma PLC’s (TCF) share price is 0.775p, making it a Sell.
Evgen Pharma PLC’s (TCF) 50-Day exponential moving average is 0.85, while Evgen Pharma PLC’s (TCF) share price is 0.775p, making it a Sell.

Evgen Pharma (TCF) Pivot Points

Jul 18, 2024, 11:34 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.82
0.83
0.82
0.83
0.82
0.83
0.82
Fibonacci
0.83
0.83
0.83
0.83
0.83
0.83
0.83
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Evgen Pharma (TCF) Moving Averages

Jul 18, 2024, 11:34 AM
Period
Simple
Exponential
MA5
0.82Sell
0.81Sell
MA10
0.84Sell
0.83Sell
MA20
0.86Sell
0.84Sell
MA50
0.82Sell
0.85Sell
MA100
0.86Sell
0.96Sell
MA200
1.26Sell
1.35Sell
Evgen Pharma PLC’s (TCF) 10-Day exponential moving average is 0.83, while Evgen Pharma PLC’s (TCF) share price is 0.775p, making it a Sell.
Evgen Pharma PLC’s (TCF) 100-Day exponential moving average is 0.96, while Evgen Pharma PLC’s (TCF) share price is 0.775p, making it a Sell.
Evgen Pharma PLC’s (TCF) stock price is 0.775p and Evgen Pharma PLC’s (TCF) 50-day simple moving average is 0.82, creating a Sell signal.
Evgen Pharma PLC’s (TCF) stock price is 0.775p and Evgen Pharma PLC’s (TCF) 100-day simple moving average is 0.86, creating a Sell signal.
Evgen Pharma PLC’s (TCF) stock price is 0.775p and Evgen Pharma PLC’s (TCF) 200-day simple moving average is 1.26, creating a Sell signal.

Evgen Pharma (TCF) Technical Indicators

Jul 18, 2024, 11:34 AM
Name
Value
Implied Action
RSI (14)
34.21
Neutral
STOCH (9,6)
18.31
Buy
STOCHRSI (14)
18.31
Buy
MACD (12,26)
>-0.01
Buy
ADX (14)
20.85
Neutral
Williams %R
-87.18
Buy
CCI (14)
-151.05
Buy
ATR (14)
0.08
-
Ultimate Oscillator
57.45
Neutral
ROC
-8.24
Sell
Evgen Pharma PLC’s (TCF) Relative Strength Index (RSI) is 34.21, creating a Neutral signal.
Evgen Pharma PLC’s (TCF) Trend Strength Indicator (ADX) is 20.85, creating a Neutral signal.
Evgen Pharma PLC’s (TCF) Commodity Channel Index (CCI) is -151.05, creating a Buy signal.
Evgen Pharma PLC’s (TCF) Price Rate of Change (ROC) is -8.24, creating a Sell signal.

FAQ

Is TCF a Buy, Hold, or Sell?
Based on TCF’s technical indicators, TCF is a Sell.
    What is TCF’s RSI (14)?
    TCF’s RSI (14) is 34.21, which suggests TCF is a Neutral.
      What is TCF’s MACD?
      TCF’s MACD is >-0.01, which suggests TCF is a Buy.
        What is TCF’s 5-day moving average?
        TCF’s 5-day moving average is 0.82, which suggests TCF is a Sell.
          What is TCF’s 20-day moving average?
          TCF 20-day moving average is 0.86, which suggests TCF is a Sell.
            What is TCF’s 50-day moving average?
            TCF’s 50-day moving average is 0.82, which suggests TCF is a Sell.
              What is TCF’s 200-day moving average?
              TCF’s 200-day moving average is 1.26, which suggests TCF is a Sell.
                What is TCF’s Williams % R (14)?
                TCF’s Williams % R (14) is -87.18, which suggests TCF is a Buy.
                  What is TCF’s CCI (14)?
                  TCF’s CCI (14) is -151.05, which suggests TCF is a Buy.
                    What is the share price of Evgen Pharma PLC?
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis